Earnings Call Perspectives, page-4

Thanks Rusty,

Excellent pick-up, missed that completely.

As always, the indicators are there, and Alan always says what he can without breaching client confidentiality.

Imagine how much combating counterfeit drugs is worth to big pharma, let alone the benefit to patients knowing they get what they pay for. Especially important when a blockbuster - like Humira - comes off patent.

Talk about product differentiaon and lifecycle management

No wonder it's taking a little longer than we might have hoped for!

Still, worth the wait